166 related articles for article (PubMed ID: 33637311)
1. A retrospective cohort study comparing a novel, spherical, resorbable particle against five established embolic agents for uterine fibroid embolisation.
Maclean D; Vigneswaran G; Bryant T; Modi S; Hacking N
Clin Radiol; 2021 Jun; 76(6):452-457. PubMed ID: 33637311
[TBL] [Abstract][Full Text] [Related]
2. Uterine Fibroid Embolization (UFE) with Optisphere: A Prospective Study of a New, Spherical, Resorbable Embolic Agent.
Hacking N; Maclean D; Vigneswaran G; Bryant T; Modi S
Cardiovasc Intervent Radiol; 2020 Jun; 43(6):897-903. PubMed ID: 32236673
[TBL] [Abstract][Full Text] [Related]
3. Initial experience of uterine fibroid embolization using porous gelatin sponge particles.
Katsumori T; Kasahara T; Oda M; Kotani T
Cardiovasc Intervent Radiol; 2011 Jun; 34(3):513-21. PubMed ID: 20574795
[TBL] [Abstract][Full Text] [Related]
4. Comparison of outcomes and cost-effectiveness of trisacryl gelatin microspheres alone versus combined trisacryl gelatin microspheres and gelatin sponge embolization in uterine fibroid embolization.
Farrell TP; Garvey C; Adams NC; Mulholland D; Ryan JM; Guiney M; McEniff N
Acta Radiol; 2020 Sep; 61(9):1287-1296. PubMed ID: 31955609
[TBL] [Abstract][Full Text] [Related]
5. The impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent.
Hacking N; Vigneswaran G; Maclean D; Bryant T; Umranikar S; Cheong Y; Modi S
Hum Fertil (Camb); 2022 Dec; 25(5):881-887. PubMed ID: 33926340
[TBL] [Abstract][Full Text] [Related]
6. Comparison of embolic agents used in uterine artery embolisation: a systematic review and meta-analysis.
Das R; Champaneria R; Daniels JP; Belli AM
Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1179-90. PubMed ID: 24305981
[TBL] [Abstract][Full Text] [Related]
7. Tris-acryl gelatin microspheres versus gelatin sponge particles in uterine artery embolization for leiomyoma.
Katsumori T; Miura H; Arima H; Hino A; Tsuji Y; Masuda Y; Nishimura T
Acta Radiol; 2017 Jul; 58(7):834-841. PubMed ID: 27799569
[TBL] [Abstract][Full Text] [Related]
8. [Amenorrhea after uterine fibroid embolization: a report of six cases].
Guo WB; Yang JY; Chen W; Zhuang WQ
Ai Zheng; 2008 Oct; 27(10):1094-9. PubMed ID: 18851791
[TBL] [Abstract][Full Text] [Related]
9. MRI assessment of uterine artery patency and fibroid infarction rates 6 months after uterine artery embolization with nonspherical polyvinyl alcohol.
Das R; Gonsalves M; Vlahos I; Manyonda I; Belli AM
Cardiovasc Intervent Radiol; 2013 Oct; 36(5):1280-7. PubMed ID: 23385663
[TBL] [Abstract][Full Text] [Related]
10. Randomised Controlled Trial of Particles Used in Uterine fibRoid Embolisation (PURE): Non-Spherical Polyvinyl Alcohol Versus Calibrated Microspheres.
Das R; Wale A; Renani SA; Ratnam L; Mailli L; Chun JY; Das S; Duggal B; Manyonda I; Belli AM
Cardiovasc Intervent Radiol; 2022 Feb; 45(2):207-215. PubMed ID: 34984488
[TBL] [Abstract][Full Text] [Related]
11. Non spherical polyvinyl alcohol versus gelatin sponge particles for uterine artery embolization for symptomatic fibroids.
Song YG; Jang H; Park KD; Kim MD; Kim CW
Minim Invasive Ther Allied Technol; 2013 Dec; 22(6):364-71. PubMed ID: 23992381
[TBL] [Abstract][Full Text] [Related]
12. Pelvic Blood Flow Predicts Fibroid Volume and Embolic Required for Uterine Fibroid Embolization: A Pilot Study With 4D Flow MR Angiography.
Malone CD; Banerjee A; Alley MT; Vasanawala SS; Roberts AC; Hsiao A
AJR Am J Roentgenol; 2018 Jan; 210(1):189-200. PubMed ID: 29090998
[TBL] [Abstract][Full Text] [Related]
13. Radiation Exposure During Uterine Fibroid Embolization (UFE): A Confounder-Controlled Comparison Between a State-of-the-Art Angiography Unit and a Conventional Angiography unit.
Sommer CM; Voigt W; Klapp Oliger M; Schlett CL; Erpenbach S; Thomas K; Hatopp A; Kurz P; Richter GM
Rofo; 2018 Mar; 190(3):250-258. PubMed ID: 28934806
[TBL] [Abstract][Full Text] [Related]
14. Can (1)H MR Spectroscopy be Used to Assess the Success of Uterine Artery Embolisation?
Macnaught G; Ananthakrishnan G; Hinksman L; Yadavali R; Bryden F; Lassman S; Ritchie M; Gallacher K; Hay C; Moss JG
Cardiovasc Intervent Radiol; 2016 Mar; 39(3):376-84. PubMed ID: 26183465
[TBL] [Abstract][Full Text] [Related]
15. Volume of embolic agents in uterine artery embolization for leiomyoma: relation to baseline MRI.
Katsumori T; Asai S; Yokota H; Miura H
Minim Invasive Ther Allied Technol; 2019 Jun; 28(3):186-193. PubMed ID: 30261778
[TBL] [Abstract][Full Text] [Related]
16. Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study.
Duvnjak S; Ravn P; Green A; Andersen PE
Acta Radiol; 2017 Aug; 58(8):952-958. PubMed ID: 27872351
[TBL] [Abstract][Full Text] [Related]
17. Does size really matter? Analysis of the effect of large fibroids and uterine volumes on complication rates of uterine artery embolisation.
Parthipun AA; Taylor J; Manyonda I; Belli AM
Cardiovasc Intervent Radiol; 2010 Oct; 33(5):955-9. PubMed ID: 20442999
[TBL] [Abstract][Full Text] [Related]
18. Uterine Artery Embolisation for Women with Giant Versus Non-giant Uterine Fibroids: A Systematic Review and Meta-analysis.
Llewellyn O; Patel NR; Mallon D; Quinn SD; Hamady M
Cardiovasc Intervent Radiol; 2020 May; 43(5):684-693. PubMed ID: 31792586
[TBL] [Abstract][Full Text] [Related]
19. Comparison of polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine fibroid embolization: results of a single-center randomized study.
Shlansky-Goldberg RD; Rosen MA; Mondschein JI; Stavropoulos SW; Trerotola SO; Diaz-Cartelle J
J Vasc Interv Radiol; 2014 Jun; 25(6):823-32. PubMed ID: 24788209
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of symptomatic fibroids treated with uterine artery embolization: in conjunction with MR evaluation.
Kim MD; Lee HS; Lee MH; Kim HJ; Cho JH; Cha SH
Eur J Radiol; 2010 Feb; 73(2):339-44. PubMed ID: 19084365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
